Bongros
Porous carbobate hydroxyapatite bone graft
1.Sinus Lift 2. GBR 3. Alveolar ridge preservation
-
The closest substance to human bone
- Optimal structure of bone and blood vessel in growth
- Standard volume extender for osteoconduction
- Solid and fast bone formation by carbonated HA
-
Indications
Indicated for filling bony voids or gaps of the skeletal system (i.e., the extremities, spine, pelvis etc.), and filling and/or augmenting intraoral/maxillofacial osseous defect.
-
Experimentation
Bongros was conjointly developed by Seoul national university department of orthopedic surgery and department of Material engineering. Animal tests and clinical trials were conducted in Seoul national university dental hospital, Seoul Asan hospital and Samsung medical center for 5 years. Based on the records, Bongros showed effective ration of 90% which has been proven to have an excellent clinical efficacy. – J. H. Lee et al. Biomed. Mater. Res.
The structure of Bongros has been recognized by the Biomaterials paper in 2000 which now is cited by over 129 SCI papers and is a treasured reference for researchers of synthetic bone graft materials around the world. – B. S. Chang et al. Biomaterials 21(2000) 1291-1298
-
Specification
rSpecification Ref.No Description HAGM0025 Bongros HAGM, 0.25g HAGM0050 Bongros HAGM, 0.50g HAGL0025 Bongros HAGL, 0.25g HAGL0050 Bongros HAGL, 0.50g HAGL0100 Bongros HAGL, 1.00g -
Research Information
Early Result of Hydroxyapatite in Bone Defect after Operative Treatment of Benign Bone Tumor